The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Gary K. Schwartz

Department of Medicine

Memorial Sloan-Kettering Cancer Center

New York

NY 10021

USA

[email]@mskcc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. 1999 - 2013
  • Department of Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Section, Memorial Sloan-Kettering Cancer Center, USA. 2001 - 2005

References

  1. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. Schwartz, G.K., Tap, W.D., Qin, L.X., Livingston, M.B., Undevia, S.D., Chmielowski, B., Agulnik, M., Schuetze, S.M., Reed, D.R., Okuno, S.H., Ludwig, J.A., Keedy, V., Rietschel, P., Kraft, A.S., Adkins, D., Van Tine, B.A., Brockstein, B., Yim, V., Bitas, C., Abdullah, A., Antonescu, C.R., Condy, M., Dickson, M.A., Vasudeva, S.D., Ho, A.L., Doyle, L.A., Chen, H.X., Maki, R.G. Lancet Oncol. (2013) [Pubmed]
  2. Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). Schwartz, G.K., Winter, K., Minsky, B.D., Crane, C., Thomson, P.J., Anne, P., Gross, H., Willett, C., Kelsen, D. J. Clin. Oncol. (2009) [Pubmed]
  3. Measuring tumor response and shape change on CT: esophageal cancer as a paradigm. Schwartz, L.H., Colville, J.A., Ginsberg, M.S., Wang, L., Mazumdar, M., Kalaigian, J., Hricak, H., Ilson, D., Schwartz, G.K. Ann. Oncol. (2006) [Pubmed]
  4. Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. Kortmansky, J., Shah, M.A., Kaubisch, A., Weyerbacher, A., Yi, S., Tong, W., Sowers, R., Gonen, M., O'reilly, E., Kemeny, N., Ilson, D.I., Saltz, L.B., Maki, R.G., Kelsen, D.P., Schwartz, G.K. J. Clin. Oncol. (2005) [Pubmed]
  5. Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors. Schwartz, G.K., Weitzman, A., O'Reilly, E., Brail, L., de Alwis, D.P., Cleverly, A., Barile-Thiem, B., Vinciguerra, V., Budman, D.R. J. Clin. Oncol. (2005) [Pubmed]
  6. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy. Schwartz, G.K. J. Clin. Oncol. (2005) [Pubmed]
  7. Targeting the cell cycle: a new approach to cancer therapy. Schwartz, G.K., Shah, M.A. J. Clin. Oncol. (2005) [Pubmed]
  8. Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer. Schwartz, G.K., Bertino, J., Kemeny, N., Saltz, L., Kelsen, D.K., Tong, W., Welch, M., Endres, S., Dimery, I. Anticancer. Drugs (2004) [Pubmed]
  9. Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. Schwartz, G.K., O'Reilly, E., Ilson, D., Saltz, L., Sharma, S., Tong, W., Maslak, P., Stoltz, M., Eden, L., Perkins, P., Endres, S., Barazzoul, J., Spriggs, D., Kelsen, D. J. Clin. Oncol. (2002) [Pubmed]
  10. Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. Schwartz, G.K., Ilson, D., Saltz, L., O'Reilly, E., Tong, W., Maslak, P., Werner, J., Perkins, P., Stoltz, M., Kelsen, D. J. Clin. Oncol. (2001) [Pubmed]
  11. Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials. Schwartz, G.K., Harstrick, A., González Barón, M. Eur. J. Cancer (1999) [Pubmed]
 
WikiGenes - Universities